British American Tobacco finalizes Russia exit with sale to local managers

British American Tobacco finalizes Russia exit with sale to local managers


British American Tobacco has finalized its exit from Russia about 18 months after it pledged to do so in the wake of Moscow’s invasion of Ukraine.

The multinational cigarette maker said in a statement Thursday it agreed “to sell its Russian and Belarusian businesses in compliance with local and international laws.”

Financial terms of the deal were not disclosed, but the transaction is expected to be completed within a month, the company said.

“Upon completion, BAT will no longer have a presence in Russia or Belarus and will receive no financial gain from ongoing sales in these markets,” it added.

Since Russia invaded Ukraine in early 2022, thousands of companies such as Apple, McDonald’s and Coca-Cola pulled out of Russia. However, other global tobacco giants are still doing business in the country, including Japan Tobacco International and Philip Morris International.

London-based BAT is a key player in the global tobacco market with business operations in over a hundred countries, and top brands including Camel and Newport.

It controlled nearly 25% of the Russia’s tobacco market, which is the fourth-largest in the world, according to Reuters.

The buyer is a consortium led by members of BAT Russia’s management team, which will wholly own the Russian and Belarusian businesses, BAT said. They will then be known as the ITMS Group.

BAT said the employment of workers in Russia will remain comparable to their existing terms for at least two years after the deal closes.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More